메뉴 건너뛰기




Volumn 209, Issue 10, 2014, Pages 1628-1634

Intestinal immunity is a determinant of clearance of poliovirus after oral vaccination

Author keywords

IgA; mucosal immunity.; polio; vaccine

Indexed keywords

CAPSID PROTEIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A ANTIBODY; ORAL POLIOMYELITIS VACCINE;

EID: 84899498418     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jit671     Document Type: Article
Times cited : (39)

References (26)
  • 1
    • 0000657364 scopus 로고
    • Emerging concept of poliomyelitis infection
    • Bodian D. Emerging concept of poliomyelitis infection. Science 1955; 122:105-8.
    • (1955) Science , vol.122 , pp. 105-108
    • Bodian, D.1
  • 2
    • 0026075384 scopus 로고
    • Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: Review
    • Patriarca PA,Wright PF, John TJ. Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review. Rev Infect Dis 1991; 13:926-39.
    • (1991) Rev Infect Dis , vol.13 , pp. 926-939
    • Patriarca, P.A.1    Wright, P.F.2    John, T.J.3
  • 3
    • 77951918630 scopus 로고    scopus 로고
    • Asymptomatic wild-type poliovirus infection in India among children with previous oral poliovirus vaccination
    • Grassly NC, Jafari H, Bahl S, et al. Asymptomatic wild-type poliovirus infection in India among children with previous oral poliovirus vaccination. J Infect Dis 2010; 201:1535-43.
    • (2010) J Infect Dis , vol.201 , pp. 1535-1543
    • Grassly, N.C.1    Jafari, H.2    Bahl, S.3
  • 4
    • 0000551263 scopus 로고
    • Immunoglobulin response in serum and secretions after immunization with live and inactivated poliovaccine and natural infection
    • Ogra PL, Karzon DT, Righthand F, MacGillivray M. Immunoglobulin response in serum and secretions after immunization with live and inactivated poliovaccine and natural infection. N Engl J Med 1968; 279: 893-900.
    • (1968) N Engl J Med , vol.279 , pp. 893-900
    • Ogra, P.L.1    Karzon, D.T.2    Righthand, F.3    MacGillivray, M.4
  • 6
    • 0027857937 scopus 로고
    • The elimination of polio in the Scandinavian countries
    • Böttiger M. The elimination of polio in the Scandinavian countries. Public Health Rev 1993-1994; 21:27-33.
    • (1993) Public Health Rev , vol.21 , pp. 27-33
    • Böttiger, M.1
  • 7
    • 34247115561 scopus 로고    scopus 로고
    • Randomized placebo-controlled trial of inactivated poliovirus vaccine in Cuba
    • Cuba IPV Study Collaborative Group
    • Cuba IPV Study Collaborative Group. Randomized, placebo-controlled trial of inactivated poliovirus vaccine in Cuba. N Engl J Med 2007; 356:1536-44.
    • (2007) N Engl J Med , vol.356 , pp. 1536-1544
  • 8
    • 84873048082 scopus 로고    scopus 로고
    • Priming after a fractional dose of inactivated poliovirus vaccine
    • Resik S, Tejeda A, Sutter RW, et al. Priming after a fractional dose of inactivated poliovirus vaccine. N Engl J Med 2013; 368:416-24.
    • (2013) N Engl J Med , vol.368 , pp. 416-424
    • Resik, S.1    Tejeda, A.2    Sutter, R.W.3
  • 10
    • 84861213998 scopus 로고    scopus 로고
    • Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge
    • Hird TR, Grassly NC. Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge. PLoS Pathog 2012; 8:e1002599.
    • (2012) PLoS Pathog , vol.8
    • Hird, T.R.1    Grassly, N.C.2
  • 11
    • 77953938095 scopus 로고    scopus 로고
    • Fractional doses of inactivated poliovirus vaccine in Oman
    • Mohammed AJ, AlAwaidy S, Bawikar S, et al. Fractional doses of inactivated poliovirus vaccine in Oman. N Engl Med 2010; 362: 2351-9.
    • (2010) N Engl Med , vol.362 , pp. 2351-2359
    • Mohammed, A.J.1    Alawaidy, S.2    Bawikar, S.3
  • 12
    • 34250971354 scopus 로고
    • 50% end-point calculation
    • Karber G. 50% end-point calculation. Arch Exp Pathol Pharmak 1931; 162:480-3.
    • (1931) Arch Exp Pathol Pharmak , vol.162 , pp. 480-483
    • Karber, G.1
  • 13
    • 0037090066 scopus 로고    scopus 로고
    • Immunoglobulin A as a serological marker for the (silent) circulation of poliovirus in an inactivated poliovirus-vaccinated population
    • Herremans T, Kimman TG, Conyn-Van Spaendonck MA, et al. Immunoglobulin A as a serological marker for the (silent) circulation of poliovirus in an inactivated poliovirus-vaccinated population. Clin Infect Dis 2002; 34:1067-75.
    • (2002) Clin Infect Dis , vol.34 , pp. 1067-1075
    • Herremans, T.1    Kimman, T.G.2    Conyn-Van Spaendonck, M.A.3
  • 14
    • 80455179632 scopus 로고    scopus 로고
    • Development of a poliovirus neutralization test with poliovirus pseudovirus for measurement of neutralizing antibody titer in human serum
    • Arita M, Iwai M, Wakita T, Shimizu H. Development of a poliovirus neutralization test with poliovirus pseudovirus for measurement of neutralizing antibody titer in human serum. Clin Vaccine Immunol 2011; 18:1889-94.
    • (2011) Clin Vaccine Immunol , vol.18 , pp. 1889-1894
    • Arita, M.1    Iwai, M.2    Wakita, T.3    Shimizu, H.4
  • 15
    • 84867472665 scopus 로고    scopus 로고
    • High-throughput, multiplexed IgG subclassing of antigen-specific antibodies from clinical samples
    • Brown EP, Licht AF, Dugast AS, et al. High-throughput, multiplexed IgG subclassing of antigen-specific antibodies from clinical samples. J Immunol Methods 2012; 386:117-23.
    • (2012) J Immunol Methods , vol.386 , pp. 117-123
    • Brown, E.P.1    Licht, A.F.2    Dugast, A.S.3
  • 16
    • 0032906950 scopus 로고    scopus 로고
    • Detection of poliovirus circulation by environmental surveillance in the absence of clinical cases in Israel and the Palestinian Authority
    • Manor Y, Handsher R, Halmut T, et al. Detection of poliovirus circulation by environmental surveillance in the absence of clinical cases in Israel and the Palestinian Authority. J Clin Microbiol 1999; 37:1670-5.
    • (1999) J Clin Microbiol , vol.37 , pp. 1670-1675
    • Manor, Y.1    Handsher, R.2    Halmut, T.3
  • 17
    • 16944366445 scopus 로고    scopus 로고
    • Combined immunization of infants with oral and inactivated poliovirus vaccines: Results of a randomized trial in the Gambia, Oman, and Thailand
    • WHO Collaborative Study Group on Oral and Inactivated Poliovirus Vaccines
    • WHO Collaborative Study Group on Oral and Inactivated Poliovirus Vaccines. Combined immunization of infants with oral and inactivated poliovirus vaccines: results of a randomized trial in The Gambia, Oman, and Thailand. J Infect Dis 1997; 175S1:S215-27.
    • (1997) J Infect Dis , Issue.175
  • 18
    • 33750277766 scopus 로고    scopus 로고
    • Quantitative analysis of poliomyelitis like paralysis in mice induced by a replicon
    • Arita M, Nagata N, Sata T, Miyamura T, Shimizu H. Quantitative analysis of poliomyelitis like paralysis in mice induced by a replicon. J Gen Virol 2006; 87:3317-27.
    • (2006) J Gen Virol , vol.87 , pp. 3317-3327
    • Arita, M.1    Nagata, N.2    Sata, T.3    Miyamura, T.4    Shimizu, H.5
  • 19
    • 0344941364 scopus 로고
    • Homologous and heterologous resistance to rhinovirus common cold
    • Fleet WF, Couch RB, Cate TR, Knight V. Homologous and heterologous resistance to rhinovirus common cold. Amer J Epid 1965; 82: 185-96.
    • (1965) Amer J Epid , vol.82 , pp. 185-196
    • Fleet, W.F.1    Couch, R.B.2    Cate, T.R.3    Knight, V.4
  • 21
    • 0018419277 scopus 로고
    • Cell-free and cell-bound antibody in nasal secretions from infants with respiratory syncytial virus infection
    • McIntosh K, McQuillin J, Gardner PS. Cell-free and cell-bound antibody in nasal secretions from infants with respiratory syncytial virus infection. Infect Immun 1979; 23:276-81.
    • (1979) Infect Immun , vol.23 , pp. 276-281
    • McIntosh, K.1    McQuillin, J.2    Gardner, P.S.3
  • 22
    • 0028812410 scopus 로고
    • Seroresponse to trivalent oral poliovirus vaccine as a function of dosage interval
    • Cohen-Abbo A, Culley BS, Reed GW, et al. Seroresponse to trivalent oral poliovirus vaccine as a function of dosage interval. Pediatr Infect Dis J 1995; 14:100-6.
    • (1995) Pediatr Infect Dis J , vol.14 , pp. 100-106
    • Cohen-Abbo, A.1    Culley, B.S.2    Reed, G.W.3
  • 23
    • 16944367385 scopus 로고    scopus 로고
    • Humoral and mucosal immunity in infants induced by three sequential inactivated poliovirus vaccine-live attenuated oral poliovirus vaccine immunization schedules. Baltimore Area Polio Vaccine Study Group
    • Modlin JF, Halsey NA, Thoms ML, Meschievitz CK, Patriarca PA. Humoral and mucosal immunity in infants induced by three sequential inactivated poliovirus vaccine-live attenuated oral poliovirus vaccine immunization schedules. Baltimore Area Polio Vaccine Study Group. J Infect Dis 1997; 175S1:S228-34.
    • (1997) J Infect Dis , vol.175
    • Modlin, J.F.1    Halsey, N.A.2    Thoms, M.L.3    Meschievitz, C.K.4    Patriarca, P.A.5
  • 24
    • 9644268227 scopus 로고    scopus 로고
    • Effect of different immunisation schedules on the excretion and reversion of oral poliovaccine strains
    • Minor PD, Dunn G, Ramsay ME, Brown D. Effect of different immunisation schedules on the excretion and reversion of oral poliovaccine strains. J Med Virol 2005; 75:153-60.
    • (2005) J Med Virol , vol.75 , pp. 153-160
    • Minor, P.D.1    Dunn, G.2    Ramsay, M.E.3    Brown, D.4
  • 25
    • 0027491318 scopus 로고
    • Shedding of virulent poliovirus revertants during immunization with oral poliovirus vaccine after prior immunization with inactivated polio vaccine
    • Abraham R, Minor P, Dunn G, Modlin JF, Ogra PL. Shedding of virulent poliovirus revertants during immunization with oral poliovirus vaccine after prior immunization with inactivated polio vaccine. J Infect Dis 1993; 168:1105-9.
    • (1993) J Infect Dis , vol.168 , pp. 1105-1109
    • Abraham, R.1    Minor, P.2    Dunn, G.3    Modlin, J.F.4    Ogra, P.L.5
  • 26
    • 69249202547 scopus 로고    scopus 로고
    • Shedding of vaccine viruses with increased antigenic and genetic divergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine
    • van der Sanden S, Pallansch MA, van de Kassteele J, et al. Shedding of vaccine viruses with increased antigenic and genetic divergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine. J Virol 2009; 83:8693-704.
    • (2009) J Virol , vol.83 , pp. 8693-8704
    • Van Der Sanden, S.1    Pallansch, M.A.2    Van De Kassteele, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.